MAHANEY PAIGE (Chief Scientific Officer) received a stock award from C4 THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/18/2026ACC: 0001470831-26-000179
Officer· Chief Scientific Officer
Since Feb 2026
+244.60K
Net shares
Net buyer
$4.6K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
247.05K acquired · 2.45K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+240K
Price / share
—
Trade value
—
% of position
241.6%
2/13/2026
99.36K→339.36K
Common Stock
Direct
Shares
+7.05K
Price / share
—
Trade value
—
% of position
2.1%
2/14/2026
332.31K→339.36K
Common Stock
Direct
Shares
−2.45K
Price / share
$1.89
Trade value
$4.62K
% of position
0.7%
2/14/2026
339.36K→336.91K
Total
Net shares
+244.60K
Net value
-$4.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2026 | A · Award | +240K | — | — | 241.6% | 99.36K | 339.36K |
| Common Stock Direct | 2/14/2026 | M · Option Exercise | +7.05K | — | — | 2.1% | 332.31K | 339.36K |
| Common Stock Direct | 2/14/2026 | F · Tax Withholding | −2.45K | $1.89 | $4.62K | 0.7% | 339.36K | 336.91K |
| Total | +244.60K | -$4.62K | ||||||
Derivative Transactions0
No derivative transactions reported